$29.32
-0.13-0.42%
Last update: Nov 12, 9:38 AM
Pfizer Inc (PFE) Stock Price, Quote, News & History
PFENYSE
Pfizer and Blackstone Life Sciences signed a $1.5 billion deal to fund berobenatide, a monthly GLP-1 obesity drug entering 10 Phase 3 trials in 2026.
You can purchase shares of Pfizer (NYSE:PFE) through any online brokerage.
Other companies in Pfizer’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Pfizer has a consensus price target of $30.59.
The stock price for Pfizer (NYSE: PFE) is $29.325 last updated November 12, 2026 at 9:38 AM EST.
There are no upcoming dividends for Pfizer.
Pfizer does not have any upcoming earnings scheduled.
There is no upcoming split for Pfizer.
Pfizer is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales....
